Wednesday, September 09, 2009 2:08:43 PM
Board Approves Reverse Stock Split
On July 20, 2009, the Board of Directors of the Company authorized a reverse split of its common stock at a ratio of one for six, effective August 14, 2009. The Company's stockholders previously approved the reverse split in September 2008. The reason to proceed with the reverse split is to broaden the range of institutions that can invest in the company's stock, increase analyst and broker interest, potentially reduce stock price volatility, reduce the number of outstanding shares and to reduce the risk of Nasdaq delisting.
As a result of the reverse split, every six shares of common stock outstanding will be combined into one share of common stock. The total number of shares of common stock outstanding will be reduced from approximately 472 million shares to approximately 78 million shares and the number of authorized shares of common stock will also be concurrently reduced on a proportional basis. The Company's common stock will begin trading on a split-adjusted basis on August 17, 2009 under the symbol "SANMD". After 20 trading days, the common stock will resume trading under "SANM".
Recent SANM News
- Sanmina's Second Quarter Fiscal 2024 Financial Results • PR Newswire (US) • 04/29/2024 08:01:00 PM
- SANMINA CORPORATION INVITES YOU TO JOIN ITS SECOND QUARTER FISCAL 2024 EARNINGS CONFERENCE CALL • PR Newswire (US) • 04/22/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:01:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 11:20:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 11:09:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 09:13:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:04:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:03:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:02:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:01:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/02/2024 10:19:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/02/2024 10:14:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:01:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/02/2024 07:22:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/01/2024 10:07:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/31/2024 07:02:07 PM
- Arcus Biosciences Stock Jumps 20% on $320M Gilead Investment, Super Micro Surpasses Forecasts, and More News • IH Market News • 01/30/2024 11:25:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 09:07:08 PM
- Sanmina's First Quarter Fiscal 2024 Financial Results • PR Newswire (US) • 01/29/2024 09:02:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/26/2024 09:31:53 PM
- SANMINA CORPORATION INVITES YOU TO JOIN ITS FIRST QUARTER FISCAL 2024 EARNINGS CONFERENCE CALL • PR Newswire (US) • 01/22/2024 09:20:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/19/2024 07:40:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 09:00:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:01:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:01:02 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM